Aspartate alleviates liver injury and regulates mRNA expressions of TLR4 and NOD signaling-related genes in weaned pigs after lipopolysaccharide challenge

J Nutr Biochem. 2014 Jun;25(6):592-9. doi: 10.1016/j.jnutbio.2014.01.010. Epub 2014 Mar 6.

Abstract

Pro-inflammatory cytokines play a critical role in many models of liver injury. In addition, aspartate (Asp) plays an important role in many biological and physiological processes including liver physiology. We hypothesized that Asp could alleviate lipopolysaccharide (LPS)-induced liver injury. Forty-eight weanling pigs were assigned to four treatments including: (1) non-challenged control; (2) LPS challenged control; (3) LPS+0.5% Asp; (4) LPS+1.0% Asp. After 20-d feeding with control (0% Asp), 0.5% or 1.0% Asp supplemented diets, pigs were injected with saline or LPS. At 4 (early phase) and 24 h (late phase) post-injection, blood and liver samples were obtained. Asp attenuated liver injury indicated by reduced serum aspartate aminotransferase activity and increased ratio of serum alanine aminotransferase and aspartate aminotransferase at 24 h, and less severe histological liver damage induced by LPS challenge at 4 or 24 h. In addition, Asp supplementation to LPS challenged pigs decreased mRNA expressions of tumor necrosis factor (TNF)-α and cyclooxygenase-2 linearly and quadratically at 4 h, and increased mRNA expressions of these pro-inflammatory mediators linearly and quadratically at 24 h. Finally, Asp decreased mRNA expression of toll-like receptor 4 (TLR4) signaling related genes (TLR4, myeloid differentiation factor 88, IL-1 receptor-associated kinase 1, TNF-α receptor-associated factor (6), nucleotide-binding oligomerization domain protein (NOD) signaling related genes (NOD1, NOD2 and receptor-interacting serine/threonine-protein kinase 2) and nuclear factor-κB p65 linearly or quadratically at 4 h. However, Asp increased mRNA expressions of these signaling molecules linearly or quadratically at 24 h. These results indicate that, at early and late phases of LPS challenge, Asp exerts opposite regulatory effects on mRNA expression of hepatic pro-inflammatory cytokines and TLR4 and NOD signalling related genes, and improves liver integrity.

Keywords: Aspartate; Lipopolysaccharide; Liver injury; Nucleotide-binding oligomerization domain protein; Pro-inflammatory cytokines; Toll-like receptor 4; Weaned pigs.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aspartic Acid / administration & dosage
  • Aspartic Acid / blood
  • Aspartic Acid / therapeutic use*
  • Biomarkers / blood
  • China
  • Crosses, Genetic
  • Dietary Supplements*
  • Disease Models, Animal*
  • Down-Regulation
  • Gene Expression Regulation, Developmental
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / blood
  • Lipopolysaccharides
  • Liver / metabolism*
  • Liver / pathology
  • Liver / physiopathology
  • Liver Diseases / metabolism
  • Liver Diseases / pathology
  • Liver Diseases / physiopathology
  • Liver Diseases / prevention & control*
  • Nod Signaling Adaptor Proteins / agonists*
  • Nod Signaling Adaptor Proteins / genetics
  • Nod Signaling Adaptor Proteins / metabolism
  • RNA, Messenger / metabolism
  • Signal Transduction
  • Sus scrofa
  • Toll-Like Receptor 4 / agonists*
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism
  • Up-Regulation
  • Weaning

Substances

  • Biomarkers
  • Inflammation Mediators
  • Lipopolysaccharides
  • Nod Signaling Adaptor Proteins
  • RNA, Messenger
  • Toll-Like Receptor 4
  • Aspartic Acid